(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m) })(window,document,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-22375394-1', 'auto'); ga('send', 'pageview');


Coalition for Epidemic Preparedness Innovations (CEPI)

CEPI is an innovative partnership between public, private, philanthropic, and civil organisations, launched at Davos in 2017, to develop vaccines against future epidemics. Prior to COVID-19, CEPI’s work focused on developing vaccines against the Ebola virus, Lassa virus, Middle East Respiratory Syndrome coronavirus, Nipah virus, Rift Valley Fever virus and Chikungunya virus. It has over 20 vaccine candidates against these pathogens in development. CEPI has also invested in new platform technologies for rapid vaccine development against unknown pathogens (Disease X).


During the current pandemic, CEPI initiated multiple programmes to develop vaccines against SARS-CoV-2 and its variants with a focus on speed, scale, and access. These programmes leverage the rapid response platforms developed by CEPI’s partners prior to the emergence of COVID-19, as well as new collaborations. The aim is to advance clinical development of a diverse portfolio of safe and effective COVID-19 candidates and to enable fair allocation of these vaccines worldwide through COVAX.


CEPI’s 5-year plan lays out a $3.5 billion roadmap to compress vaccine development timelines to 100 days, develop a broadly protective vaccine against COVID-19 and other Beta coronaviruses, and create a “library” of vaccine candidates for use against known and unknown pathogens.


CEPI is an equal opportunity employer and provides a diverse and inclusive work environment. You can find further details on their website https://cepi.net/


Role purpose

To deliver a portfolio management strategy where analytical insight and expert judgement drive effective, efficient and robust investment decision-making.


Duties and Responsibilities

  • Act as a strategic partner to CEPI senior leadership, portfolio and project leaders, and governance groups by providing objective and independent strategic portfolio decision and analysis to enable effective portfolio management, prioritisation, and delivery  
  • Deliver consistent & accurate internal and external reporting of the pipeline, and ensure an effective view of performance analysis including through , and partnering with Research & Development (R&D) and Manufacturing & Supply Chain (M&SC) on technical analytics to allow a consistent current and future view of the portfolio and to inform project and portfolio decision-making and prioritization
  • Have overall responsibility for and orchestrate CEPI’s approach to project/portfolio governance, including:
  • Driving a cross-functional approach to strategic portfolio decision-making, drawing on strategic insights from across CEPI (including R&D, M&SC, partnerships and access)
  • Working with partners internally to ensure a joined-up set of governance and oversight processes
  • Ensuring a constant focus on portfolio governance and reporting processes that are right-sized -– both robust and agile
  • Providing overall leadership for the management and continuous improvement of the Portfolio Strategy & Management Board (PSMB), contribute to the VRDMC (Vaccine Research & Development & Manufacturing Committee) (led by R&D), and leading on the annual portfolio review process working in partnership with R&D and M&SC
  • Provide leadership:
  • Lead the portfolio department and the development of the function and the team members
  • Serve as a member of the PSMB, as a member of the GSP leadership team, and as part of CEPI’s wider leadership group.  
  • Play a critical role in cross-business projects relating to governance, systems, and processes; supporting continuous improvement in CEPI’s internal work and awardee interactions



Education, Qualifications & Experience

  • PHD in a related discipline. MBA of potential value  
  • Experience working in industry/R&D/vaccine portfolio management
  • Proven track record in portfolio management and analytics  
  • Proven analytical skills and affinity with complex data sets, with pharmaceutical sector experience or experience of close working with the pharmaceutical sector. Experience R&D funding sector beneficial
  • Proven success as a thought-partner to senior stakeholders and a trusted advisor to leaders
  • Ability to provide clear, effective and efficient pathways to resolving ambiguous questions  
  • Strong matrix leadership skills, able to build strong relationships at all levels, exercise diplomatic leadership, and bring people along
  • Recognised as having in-depth knowledge of the R&D and M&SC process and credibility within R&D and M&SC Leaders
  • Highly proficient in spoken and written English


Terms of Appointment

This is a full-time position. Salary is competitive and commensurate with qualifications and experience. A benefits package is also included.


Role Location

This role can be based in London (UK), Oslo (NO) or Washington DC (US).


How to Apply


If you wish to be considered for this position, please complete the Application Form below on or before 27 January 2023. In addition, we encourage you to please attach a copy of the most recent English version of your CV.


All information will be treated in the strictest confidence.


If you have an initial query rather than an application, kindly email us at DOPM@sri-executive.com




SRI Executive is exclusively retained by the Coalition for Epidemic Preparedness Innovations (CEPI) to undertake this assignment.


Application form

Personal Details
Work Experience
Attach Resume
Required Field
Any Additional Documentation (Optional)